Andrew Tatham, MD, MBA, FRCOphth, FEBO, outlines the role of micro-invasive glaucoma surgery alongside established glaucoma ...

NYU Grossman’s Preeya Mehta, MD, and Jonathan S. Williams, MD, sit down with Mount Sinai’s Louis R. Pasquale, MD, to discuss long-term safety and efficacy data from a PreserFlo microshunt trial and ...

Nitinol has arrived in minimally invasive glaucoma surgery, making symptom management for the progressive eye disease safer and personalized.

Glaucoma often remains asymptomatic until vision damage occurs, with angle-closure glaucoma requiring urgent medical attention due to acute symptoms. Risk factors include family history, age, ...

Cases of this eye condition are expected to increase around the world to 22 million by the year 2040. The key to holding onto your vision is getting diagnosis and treatment early.

GDDs significantly increase corneal edema risk compared to trabeculectomy, with a 27.7% incidence versus 13.5% for trabeculectomy. MIGS and Xen stents show lower risks for corneal edema, with ...

Please provide your email address to receive an email when new articles are posted on . A lower Glaucoma Medication Intensity Index (GMII) was tied to longer surgical success duration. Older age at ...

Glaucoma is a leading cause of irreversible blindness because it progresses silently, often without early symptoms. Experts ...

Please provide your email address to receive an email when new articles are posted on . Ptosis and strabismus occurred in 3.7% and 1.7% of patients, respectively, and 1% had both. Most patients in all ...

ALEXANDRIA, MN - January 24, 2026 - PRESSADVANTAGE - Individuals living with or at risk for glaucoma in the region can ...